NO20023389L - Nye benzensulfonamid-forbindelser, fremgangsmåte ved deres fremstilling ogfarmasöytiske sammensetninger inneholdende dem - Google Patents
Nye benzensulfonamid-forbindelser, fremgangsmåte ved deres fremstilling ogfarmasöytiske sammensetninger inneholdende demInfo
- Publication number
- NO20023389L NO20023389L NO20023389A NO20023389A NO20023389L NO 20023389 L NO20023389 L NO 20023389L NO 20023389 A NO20023389 A NO 20023389A NO 20023389 A NO20023389 A NO 20023389A NO 20023389 L NO20023389 L NO 20023389L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- methods
- pharmaceutical compositions
- compositions containing
- benzenesulfonamide compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0109338A FR2827287B1 (fr) | 2001-07-13 | 2001-07-13 | Nouveaux derives de benzene sulfonamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20023389D0 NO20023389D0 (no) | 2002-07-12 |
| NO20023389L true NO20023389L (no) | 2003-01-14 |
| NO323868B1 NO323868B1 (no) | 2007-07-16 |
Family
ID=8865461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20023389A NO323868B1 (no) | 2001-07-13 | 2002-07-12 | Nye benzensulfonamid-forbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6589956B2 (no) |
| EP (1) | EP1275644A1 (no) |
| JP (1) | JP4138382B2 (no) |
| KR (1) | KR100498864B1 (no) |
| CN (1) | CN1168715C (no) |
| AR (1) | AR036340A1 (no) |
| AU (1) | AU2002300093B2 (no) |
| BR (1) | BR0202674A (no) |
| CA (1) | CA2394037C (no) |
| EA (1) | EA005403B1 (no) |
| FR (1) | FR2827287B1 (no) |
| HK (1) | HK1050681A1 (no) |
| HU (1) | HUP0202286A2 (no) |
| MX (1) | MXPA02006852A (no) |
| NO (1) | NO323868B1 (no) |
| NZ (1) | NZ520140A (no) |
| PL (1) | PL354948A1 (no) |
| ZA (1) | ZA200205598B (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8097610B2 (en) * | 2005-08-26 | 2012-01-17 | Shionogi & Co., Ltd. | Derivative having PPAR agonistic activity |
| US10093640B2 (en) | 2012-09-21 | 2018-10-09 | Vanderbilt University | Substituted benzofuran, benzothiophene and indole MCL-1 inhibitors |
| WO2015031608A1 (en) | 2013-08-28 | 2015-03-05 | Vanderbilt University | Substituted indole mcl-1 inhibitors |
| US10533010B2 (en) | 2014-03-27 | 2020-01-14 | Vanderbilt University | Substituted indole Mcl-1 inhibitors |
| US9949965B2 (en) | 2014-10-17 | 2018-04-24 | Vanderbilt University | Tricyclic indole Mcl-1 inhibitors and uses thereof |
| AU2017228385B2 (en) | 2016-03-04 | 2021-11-04 | Vanderbilt University | Substituted indole Mcl-1 inhibitors |
| WO2021132311A1 (ja) * | 2019-12-24 | 2021-07-01 | 大日本住友製薬株式会社 | 脂肪族酸アミド誘導体 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3468882A (en) * | 1966-10-07 | 1969-09-23 | Sterling Drug Inc | Phenylhydrazone derivatives as intermediates for preparing indoles |
| GB8419575D0 (en) * | 1984-08-01 | 1984-09-05 | Glaxo Group Ltd | Chemical compounds |
| KR940007458B1 (ko) * | 1991-11-21 | 1994-08-18 | 주식회사 금성사 | 박막 트랜지스터 제조 방법 |
| TW219358B (no) * | 1991-12-20 | 1994-01-21 | Hokuriku Pharmaceutical | |
| CA2152160A1 (en) * | 1992-12-21 | 1994-07-07 | Tomoyuki Ikemoto | N-substituted indole derivative |
| GB9317764D0 (en) * | 1993-08-26 | 1993-10-13 | Pfizer Ltd | Therapeutic compound |
| FR2712591B1 (fr) * | 1993-11-19 | 1996-02-09 | Pf Medicament | Nouvelles arylpipérazines dérivées d'indole, leur préparation et leur utilisation thérapeutique. |
| US6043264A (en) * | 1995-01-06 | 2000-03-28 | Toray Industries, Inc. | Benzene-condensed heterocyclic derivatives and their uses |
| US5998415A (en) * | 1995-11-02 | 1999-12-07 | Merck Sharp & Dohme Ltd. | Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation, and their use of as selective agonists of 5-HT1 -like receptors |
| GB9523243D0 (en) * | 1995-11-14 | 1996-01-17 | Merck Sharp & Dohme | Therapeutic agents |
| GB9523250D0 (en) * | 1995-11-14 | 1996-01-17 | Merck Sharp & Dohme | Therapeutic agents |
-
2001
- 2001-07-13 FR FR0109338A patent/FR2827287B1/fr not_active Expired - Fee Related
-
2002
- 2002-07-08 PL PL02354948A patent/PL354948A1/xx not_active Application Discontinuation
- 2002-07-10 JP JP2002200910A patent/JP4138382B2/ja not_active Expired - Fee Related
- 2002-07-10 BR BR0202674-0A patent/BR0202674A/pt not_active IP Right Cessation
- 2002-07-11 EP EP02291746A patent/EP1275644A1/fr not_active Withdrawn
- 2002-07-11 MX MXPA02006852A patent/MXPA02006852A/es active IP Right Grant
- 2002-07-12 NZ NZ520140A patent/NZ520140A/en unknown
- 2002-07-12 ZA ZA200205598A patent/ZA200205598B/xx unknown
- 2002-07-12 AU AU2002300093A patent/AU2002300093B2/en not_active Ceased
- 2002-07-12 EA EA200200665A patent/EA005403B1/ru not_active IP Right Cessation
- 2002-07-12 AR ARP020102608A patent/AR036340A1/es not_active Application Discontinuation
- 2002-07-12 NO NO20023389A patent/NO323868B1/no not_active IP Right Cessation
- 2002-07-12 US US10/195,031 patent/US6589956B2/en not_active Expired - Fee Related
- 2002-07-12 HU HU0202286A patent/HUP0202286A2/hu unknown
- 2002-07-13 KR KR10-2002-0040945A patent/KR100498864B1/ko not_active IP Right Cessation
- 2002-07-15 CN CNB021241619A patent/CN1168715C/zh not_active Expired - Fee Related
- 2002-07-15 CA CA002394037A patent/CA2394037C/fr not_active Expired - Fee Related
-
2003
- 2003-04-17 HK HK03102798A patent/HK1050681A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4138382B2 (ja) | 2008-08-27 |
| FR2827287A1 (fr) | 2003-01-17 |
| MXPA02006852A (es) | 2005-07-25 |
| CA2394037A1 (fr) | 2003-01-13 |
| FR2827287B1 (fr) | 2003-10-31 |
| BR0202674A (pt) | 2003-05-06 |
| ZA200205598B (en) | 2003-03-27 |
| EA200200665A1 (ru) | 2003-02-27 |
| AR036340A1 (es) | 2004-09-01 |
| US20030109533A1 (en) | 2003-06-12 |
| CN1168715C (zh) | 2004-09-29 |
| HU0202286D0 (no) | 2002-09-28 |
| CN1397550A (zh) | 2003-02-19 |
| KR100498864B1 (ko) | 2005-07-04 |
| KR20030007173A (ko) | 2003-01-23 |
| PL354948A1 (en) | 2003-01-27 |
| JP2003064055A (ja) | 2003-03-05 |
| HK1050681A1 (en) | 2003-07-04 |
| NZ520140A (en) | 2003-09-26 |
| EA005403B1 (ru) | 2005-02-24 |
| AU2002300093B2 (en) | 2007-07-12 |
| US6589956B2 (en) | 2003-07-08 |
| HUP0202286A2 (hu) | 2003-08-28 |
| NO20023389D0 (no) | 2002-07-12 |
| EP1275644A1 (fr) | 2003-01-15 |
| CA2394037C (fr) | 2008-04-29 |
| NO323868B1 (no) | 2007-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20013254L (no) | Nye difenylureaforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske samensetninger som inneholder dem | |
| NO20022285L (no) | Nye <alfa>-aminosyreforbindelser, fremgangsmÕte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO996250D0 (no) | Nye hydrazidforbindelser, fremgangsmåte ved deres fremstilling og farmasoeytiske sammensetninger inneholdende dem | |
| NO20042805L (no) | Nye forbindelser og deres anvendelse innen medisin, fremgangsmate for deres fremstilling og farmaoytiske sammensetninger som inneholder dem | |
| NO20010522L (no) | Nye piperidin-4-sulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem | |
| NO20014945L (no) | Nye cyklonbutendionforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20026154D0 (no) | Nye substituerte ftalider, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20010305L (no) | Nye benzensulfonamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20023389L (no) | Nye benzensulfonamid-forbindelser, fremgangsmåte ved deres fremstilling ogfarmasöytiske sammensetninger inneholdende dem | |
| NO20021330D0 (no) | Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20021198L (no) | Nye isoindoloindolonforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20013710L (no) | Nye benzotiadiazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20023345D0 (no) | Nye oktahydro-2H-pyrido[1-2-a]pyrazinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiskesammensetninger inneholdende dem | |
| NO20031643D0 (no) | Nye aminotriazolonforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20023409L (no) | Nye N-benzylpiperazinforbindelser, fremgangsmåte ved deres fremstilling ogfarmasöytiske sammensetninger inneholdende dem | |
| NO20042978L (no) | Nye benzotiazin- og benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20035215D0 (no) | Tricykliske dihydrokinolinforbindelser, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20016069D0 (no) | Nye bicykliske amino-pyrazinonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdendedem | |
| NO20041313L (no) | Nye isokinolinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
| NO20021806D0 (no) | Nye pyrimidin-4-on-forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20023390D0 (no) | Nye benzensulfonamid-forbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20022794L (no) | Nye indenoindolonforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20020262D0 (no) | Nye cykloheptenforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20011862L (no) | Nye heterocykloalkylbenzocyklobutan- og heteroarylbenzocyklobutanforbindelser, fremgangsmåte ved deresfremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20010801D0 (no) | Nye 6-amino- eller 6-hydroazino-sulfonyl-3- kinolynylfosfonsyreforbindelse, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |